STOK (STOCKS)
Stoke Therapeutics, Inc. Common Stock
$30.000000
+0.180000 (+0.60%)
Prev close: $29.820000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ian Frederick Smith
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,869.39M
- Employees
- 128
- P/E (TTM)
- -10.56
- P/B (TTM)
- 4.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.79 | $-0.84 | +0.0535 | +6.34% |
|
Dec 2025 (Q4)
|
$-0.97 | $-0.73 | -0.2421 | -33.26% |
|
Sep 2025 (Q3)
|
$-0.65 | $-0.58 | -0.0703 | -12.13% |
|
Jun 2025 (Q2)
|
$-0.40 | $-0.52 | +0.1222 | +23.40% |
Financial Statements
| Revenues | $32.08M |
| Benefits Costs and Expenses | $203.13M |
| Costs And Expenses | $203.13M |
| Nonoperating Income/Loss | $14.20M |
| Operating Expenses | $217.33M |
| Selling, General, and Administrative Expenses | $72.41M |
| Research and Development | $144.92M |
| Operating Income/Loss | -$185.25M |
| Income/Loss From Continuing Operations After Tax | -$169.77M |
| Income/Loss From Continuing Operations Before Tax | -$171.05M |
| Income Tax Expense/Benefit | -$1.28M |
| Interest Expense, Operating | $32.00K |
| Net Income/Loss | -$169.77M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$169.77M |
| Net Income/Loss Available To Common Stockholders, Basic | -$169.77M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.84 |
| Diluted Earnings Per Share | -$2.81 |
| Basic Average Shares | 180,969,411 |
| Diluted Average Shares | 178,850,542 |
| Assets | $443.28M |
| Current Assets | $366.68M |
| Prepaid Expenses | $10.12M |
| Other Current Assets | $356.57M |
| Noncurrent Assets | $76.60M |
| Fixed Assets | $3.40M |
| Other Non-current Assets | $73.20M |
| Liabilities | $48.40M |
| Current Liabilities | $40.81M |
| Accounts Payable | $6.84M |
| Other Current Liabilities | $33.97M |
| Noncurrent Liabilities | $7.59M |
| Equity | $394.88M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $394.88M |
| Liabilities And Equity | $443.28M |
| Net Cash Flow From Operating Activities | -$146.82M |
| Net Cash Flow From Operating Activities, Continuing | -$146.82M |
| Net Cash Flow From Investing Activities | -$149.75M |
| Net Cash Flow From Investing Activities, Continuing | -$149.75M |
| Net Cash Flow From Financing Activities | $180.34M |
| Net Cash Flow From Financing Activities, Continuing | $180.34M |
| Net Cash Flow | -$116.23M |
| Net Cash Flow, Continuing | -$116.23M |
| Comprehensive Income/Loss | -$169.98M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$169.78M |
| Other Comprehensive Income/Loss | -$11.00K |